Product Images Aripiprazole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 13 images provide visual information about the product associated with Aripiprazole NDC 60505-2676 by Apotex Corp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

10mg30s.jpg - 10mg30s

10mg30s.jpg - 10mg30s

Each tablet of Aripiprazole contains 10mg of the drug. The tablets should be stored at a temperature range of 20°C to 25°C and excursions are permitted from 15°C to 30°C. The recommended storage container is a tight container as per USP guidelines. The usual dosage is advised to be checked by referring to the package insert. The product comes in a pack size of 30 tablets with product code NDC 60505-2674-3. The medication should be dispensed by a pharmacist along with the medication guide. The manufacturer is Apotex Inc. in Ontario, Canada, and is available for purchase on their website.*

15mg30s.jpg - 15mg30s

15mg30s.jpg - 15mg30s

Each tablet contains 15 mg of aripiprazole. Store at 20°C 10 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (50°F to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight container [see USP]. Usual dosage: See package insert. 30 Tablets NDC 60505-2675-3. Pharmacist: Dispense with Medication Guide. Manufactured by Apotex Inc, Toronto, Ontario, Canada M9L 1N7. Available at www.apotex.com/products/us. Only APOTEX CORP.*

20mg30s.jpg - 20mg30s

20mg30s.jpg - 20mg30s

This is the description: This is a medication with 20mg of Aripiprazole per tablet. It should be stored in a tight container at a temperature of 20°C to 25°C, with excursions permitted from 15°C to 30°C. The medication guide should be dispensed by the pharmacist and it is available at https://apotex.com/products/us.*

2mg30s.jpg - 2mg30s

2mg30s.jpg - 2mg30s

Each tablet of Aripiprazole USP contains 2mg of the active ingredient. The tablets should be stored at a temperature range of 20°C to 25°C (68°F to 77°F), with excursions permitted from 15°C to 30°C (59°F to 86°F). They should be dispensed in a tight container and a Medication Guide and package insert are available at www.apotex.com/products/us. Manufactured by Apotex Inc. in Toronto, Canada and made for Apotex Corp. in Weston, Florida. NDC 60505-3075-3.*

30mg30s.jpg - 30mg30s

30mg30s.jpg - 30mg30s

Each tablet of Aripiprazole USP contains 30 mg of the active ingredient. The tablets should be stored in a tightly sealed container and in a controlled room temperature between 20°C to 25°C. Excursions are permitted from 15°C to 30°C. For usual dosage, please refer to the package insert. A medication guide is available at your local pharmacy. This product is manufactured by Apotex Corp. in Ontario, Canada and is dispensed with a Medication Guide.*

5mg30s.jpg - 5mg30s

5mg30s.jpg - 5mg30s

This is a description of a medication called Aripiprazole in tablet form. Each tablet contains 5mg of Aripiprazole. The tablets should be stored at a temperature range of 20°C to 25°C with permitted excursions between 15°C and 30°C. The tablets should be dispensed in a tight container, and the medication guide is available at the website w1.apotex.com/products/us. The tablets are manufactured by Apotenc in Toronto, Canada, and they are intended for distribution by Apotex Corp in Weston, Florida.*

Figure_1.jpg - Figure 1

Figure_1.jpg - Figure 1

Figure_2.jpg - Figure 2

Figure_2.jpg - Figure 2

This is a list of drugs and their effects on Aripiprazole PK (pharmacokinetics). The list includes inhibitors and inducers of specific enzymes (CYP3A4 and CYP206) and their impact on the levels of Aripiprazole in the body. Additionally, it mentions the effect of gastric acid blockers, valproate, lithium, and lorazepam on Aripiprazole. Finally, there is a graph that shows the change in Dehydro-Aripiprazole Fold Ghange relative to the reference without interacting drugs.*

Figure_3.jpg - Figure 3

Figure_3.jpg - Figure 3

The given text seems to be a graph or chart that shows the effects of Aripiprazole on other drugs. It displays the fold change in CYP2D6 PK and 90% G and lists various drugs such as warfarin, omeprazole, lamotrigine, valproate, lithium, lorazepam, escitalopram, and more. Unfortunately, the chart is not readable so a useful description cannot be provided.*

Figure_4.jpg - Figure 4

Figure_4.jpg - Figure 4

The text seems to contain incomplete and unclear information regarding special populations, age, hepatic impairment, and renal impairment. Therefore, it is not possible to generate a useful description.*

Figure_5.jpg - Figure 5

Figure_5.jpg - Figure 5

Figure_6.jpg - Figure 6

Figure_6.jpg - Figure 6

This appears to be a table or graph related to a study on the use of Aripiprazole and Placebo in treating a condition called "Proprion itk Relapso". The table shows the number of subjects at risk for each treatment group over a period of time measured in days from randomization. Unfortunately, no further details on the study or results are available from this text.*

chemical-structure - aripiprazole 01

chemical-structure - aripiprazole 01

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.